FDA Inspection 1297960 — Piotr Lacwik
The FDA completed an inspection of Piotr Lacwik on December 12, 2025 in Czerwona Gora. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- December 12, 2025
- Fiscal Year
- 2026
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Czerwona Gora (Poland)
Additional Details
Clinical Investigator (CI)